Oseltamivir phosphate-amberliteTM IRP 64 ionic complex for taste masking: Preparation and chemometric evaluation

Journal of Pharmaceutical Sciences

Volumn 102, Issue 6, 2013, Pages 1800-1812

  Siddiqui, Akhtar ^a   Shah, Rakhi B ^a   Khan, Mansoor A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Complexation; FTIR; Ionpair complex; Multivariate Analysis; Near Infrared Spectroscopy; Oseltamivir; Principal component Analysis; Resins; Taste masking

Indexed keywords

OSELTAMIVIR; POLACRILIN; RESIN;

ARTICLE; BITTER TASTE; CHEEK MUCOSA; CHEMOMETRICS; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; NEAR INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; STOMACH PH; TASTE; X RAY POWDER DIFFRACTION;

EID: 84877926701     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23518     Document Type: Article

References (34)

1. Ong AK, Hayden FG, John f. 2007. Enders lecture 2006: Antivirals for influenza. J Infect Dis 196:181-190.
2. Ward P, Small I, Smith J, Suter P, Dutkowski R. 2005. Oseltamivir (tamiflu®) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55:i5-i21.
3. Genentech AMotRG. 2012. Help your child feel better. Accessed, at: web:http://www.tamiflu.com/children/treat.html last accessed 03/20/2012.
4. Douroumis D. 2007. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv 4:417-426.
5. Gowthamarajan K, Kulkarni G, Kumar M. 2004. Pop the pills without bitterness. Reson 9:25-32.
6. Guo X, Chang R-K, Hussain MA. 2009. Ion-exchange resins as drug delivery carriers. J Pharm Sci 98:3886-3902.
7. Kayumba PC, Huyghebaert N, Cordella C, Ntawukuliryayo JD, Vervaet C, Remon JP. 2007. Quinine sulphate pellets for flexible pediatric drug dosing: Formulation development and evaluation of taste-masking efficiency using the electronic tongue. Eur J Pharm Biopharm 66:460-465.
8. Suzuki H, Onishi H, Takahashi Y, Iwata M, Machida Y. 2003. Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm 251:123-132.
9. Katsuragi Y, Mitsui Y, Umeda T, Otsuji K, Yamasawa S, Kurihara K. 1997. Basic studies for the practical use of bitterness inhibitors: Selective inhibition of bitterness by phospholipids. Pharm Res 14:720-724.
10. Agarwal R, Mittal R, Singh A. 2000. Studies of ion-exchange resin complex of chloroquine phosphate. Drug Dev Ind Pharm 26:773-776.
11. Shiraishi S, Imai T, Otagiri M. 1993. Controlled release of indomethacin by chitosan-polyelectrolyte complex: Optimization Land in vivo/in vitro evaluation. J Control Release 25:217-225.
12. Roche F, LH-L 2006. Tamiflu monograph. Accessed, at: http://www.Gripp.Ee/files/17_tamiflu_product_monograph.pdf last accessed 03/20/2012.
13. Mundada AS, Meshram DR, Banbale HB, Avari JG, Bhalekar MR. 2008. Formulation and evaluation of dispersible taste masked tablet of roxithromycin. Asian J Pharm 2:116-119.
14. Tawakkul MA, Shah RB, Zidan A, Sayeed VA, Khan MA. 2009. Complexation of risperidone with a taste-masking resin: Novel application of near infra-red and chemical imaging to evaluate complexes. Pharm Dev Technol 14:409-421.
15. Shah RB, Tawakkul MA, Sayeed VA, Khan MA. 2009. Complexation between risperidone and amberlite resin by various methods of preparation and binding study. Drug Dev Ind Pharm 35:1409-1418.
16. Sateesha SB, Rajamma AJ, Shekhar HS, Divakar GG. 2011. Formulation development and rheological studies of palatable cefetamet pivoxil hydrochloride dry powder suspension. CORD Conf Proc 19:118-125.
17. TM IRP 64 pharmaceutical grade cation exchange resin. Accessed, at: http://www.rohmhaas.com/ionexchange/pharmaceuticals/Formulations_doc/us_english/Irp64.PDF.
18. Hassan MA, Suleiman MS, Najib NM. 1990. Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin. Int J Pharm 58:19-24.
19. Nie S FX, Peng Y, Yang X, Wang C, Pan W. 2007. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin. Arch Pharm Res 30:991-1001.
20. Rahman Z, Zidan AS, Khan MA. 2010. Risperidone solid dispersion for orally disintegrating tablet: Its formulation design and non-destructive methods of evaluation. Int J Pharm 400:49-58.
21. Xiang D, Berry J, Buntz S, Gargiulo P, Cheney J, Joshi Y, Wabuyele B, Wu H, Hamed M, Hussain AS, Khan MA. 2009. Robust calibration design in the pharmaceutical quantitative measurements with near-infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls. J Pharm Sci 98:1155-1166.
22. Sabin GP, Breitkreitz MC, de Souza AM, da Fonseca P, Calefe L, Moffa M, Poppi RJ. 2011. Analysis of pharmaceutical pellets: An approach using near-infrared chemical imaging. Anal Chim Acta 706:113-119.
23. Hilden LR, Pommier CJ, Badawy SIF, Friedman EM. 2008. NIR chemical imaging to guide/support BMS-561389 tablet formulation development. Int J Pharm 353:283-290.
24. Ravn C, Skibsted E, Bro R. 2008. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-Comparing common calibration approaches. J Pharm Biomed Anal 48:554-561.
25. Puchert T, Lochmann D, Menezes JC, Reich G. 2010. Near-infrared chemical imaging (NIR-CI) for counterfeit drug identification-A four-stage concept with a novel approach of data processing (linear image signature). J Pharm Biomed Anal 51:138-145.
26. Li W, Woldu A, Kelly R, McCool J, Bruce R, Rasmussen H, Cunningham J, Winstead D. 2008. Measurement of drug agglomerates in powder blending simulation samples by near infrared chemical imaging. Int J Pharm 350:369-373.
27. Palou A, Cruz J, Blanco M, Tomàs J, de los Ríos J, Alcalà M. 2012. Determination of drug, excipients and coating distribution in pharmaceutical tablets using NIR-CI. J Pharm Anal 2:90-97.
28. Ma H, Anderson CA. 2008. Characterization of pharmaceutical powder blends by nir chemical imaging. J Pharm Sci 97:3305-3320.
29. Zidan AS, Rahman Z, Khan MA. 2012. Chemometric evaluation of brompheniramine-tannate complexes. J Pharm Sci 101:1450-1461.
30. Gowen AA, O'Donnell CP, Cullen PJ, Bell SEJ. 2008. Recent applications of chemical imaging to pharmaceutical process monitoring and quality control. Eur J Pharm Biopharm 69:10-22.
31. Becket G, Schep LJ, Tan MY. 1999. Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins. Int J Pharm 179:65-71.
32. Dai WG, Dong LC, Song YQ. 2007. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate. Int J Pharm 342:201-207.
33. Lorenz JK, Reo JP, Hendl O, Worthington JH, Petrossian VD. 2009. Evaluation of a taste sensor instrument (electronic tongue) for use in formulation development. Int J Pharm 367:65-72.
34. Rahman Z, Zidan AS, Berendt RT, Khan MA. 2012. Tannate complexes of antihistaminic drug: Sustained release and taste masking approaches. Int J Pharm 422:91-100.